The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: quetiapine     Quarter: 2016Q3

Total Drug/Injury Combinations: 857     Number of Pages: 43

DRUGNAME PT EventCount
QUETIAPINE. Retinal vein occlusion 2 view events
QUETIAPINE. Sinus tachycardia 2 view events
QUETIAPINE. Suicidal ideation 2 view events
QUETIAPINE. Swelling face 2 view events
QUETIAPINE. Thrombocytopenic purpura 2 view events
QUETIAPINE. Tic 2 view events
QUETIAPINE. Tongue biting 2 view events
QUETIAPINE /01270902/ Depressed mood 1 view events
QUETIAPINE /01270902/ Depression 1 view events
QUETIAPINE /01270902/ Tearfulness 1 view events
Quetiapine (AGPTC) Thrombotic thrombocytopenic purpura 1 view events
QUETIAPINE (NGX) Blindness 1 view events
QUETIAPINE (NGX) Blood testosterone decreased 1 view events
QUETIAPINE (NGX) Drug ineffective 1 view events
QUETIAPINE (NGX) Drug intolerance 1 view events
QUETIAPINE (NGX) Pituitary tumour 1 view events
QUETIAPINE (NGX) Product use issue 1 view events
QUETIAPINE (NGX) Seizure 1 view events
QUETIAPINE (NGX) Tooth disorder 1 view events
QUETIAPINE (NGX) Tooth loss 1 view events

Total Drug/Injury Combinations: 857     Number of Pages: 43

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)